Biovail Marantz dvd NYSE BVF TSX BVF announced that it has received a Notice of Compliance from the Therapeutic Products Directorate TPD for its supplemental New Drug Submission sNDS for a new indication for Wellbutrin reg. Physicians who already appreciate the unique combination of first line efficacy with low incidence of sexual dysfunction and weight gain offered by Wellbutrin reg.
Announced that it has received a Notice of Compliance from the Therapeutic Products Directorate. The prevention of major depressive illness with an autumn. Bioivail gets Canadian approval for new indication of Wellbutrin. XL for the Prevention of Seasonal Major Depressive Illness. Biovail Corporation today announced that it has received a Notice of Compliance from the Therapeutic Products Directorate for its supplemental New Drug Submission for a new indication for Wellbutrin.